Allergan Plc (AGN) - Financial and Strategic SWOT Analysis Review

Allergan Plc (AGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology, womens health, urology and anti-infective therapeutic categories. The company sells its products to retailers, drug wholesalers and distributors, including national retail drug and food store chains, mail order retailers, hospitals, clinics, government agencies and managed healthcare providers such as health maintenance organizations and other institutions. It has operations in several countries across the Americas, Europe, Asia-Pacific, the Middle East and Africa. Allergan is headquartered in Dublin, Ireland.

Allergan Plc Key Recent Developments

Feb 21,2018: New report shines light on disconnect between patient and physicians when it comes to the seriousness of IBS, leading to slow diagnosis
Feb 16,2018: Allergan Presents Data at the 2018 American Academy of Dermatology (AAD) Annual Meeting in San Diego
Feb 06,2018: Allergan Reports Total Net Revenue Of $4.33 Billion In The Fourth Quarter Of 2017
Feb 05,2018: Allergan Appoints Matthew M. Walsh As Executive Vice President and Chief Financial Officer
Jan 08,2018: Allergan Provides 2018 Preliminary Financial Outlook for Select Income Statement Categories and Other Updates at 36th Annual J. P. Morgan Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company




Section 1 - About the Company 6
Allergan Plc - Key Facts 6
Allergan Plc - Key Employees 7
Allergan Plc - Key Employee Biographies 8
Allergan Plc - Major Products and Services 10
Allergan Plc - History 12
Allergan Plc - Company Statement 23
Allergan Plc - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Section 2 Company Analysis 32
Company Overview 32
Allergan Plc - Business Description 32
Business Segment: International Brands Segment 32
Overview 32
Performance 32
Business Segment: US General Medicine Segment 33
Overview 33
Performance 33
Business Segment: US Specialized Therapeutics Segment 33
Overview 33
Performance 33
R&D Overview 34
Allergan Plc - Corporate Strategy 35
Allergan Plc - SWOT Analysis 36
SWOT Analysis - Overview 36
Allergan Plc - Strengths 36
Allergan Plc - Weaknesses 37
Allergan Plc - Opportunities 38
Allergan Plc - Threats 39
Allergan Plc - Key Competitors 40
Section 3 Company Financial Ratios 41
Financial Ratios - Capital Market Ratios 41
Financial Ratios - Annual Ratios 42
Performance Chart 45
Financial Performance 45
Financial Ratios - Interim Ratios 46
Financial Ratios - Ratio Charts 47
Section 4 Companys Lifesciences Financial Deals and Alliances 48
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 48
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 49
Allergan Plc, Recent Deals Summary 50
Section 5 Companys Recent Developments 51
Feb 21, 2018: New report shines light on disconnect between patient and physicians when it comes to the seriousness of IBS, leading to slow diagnosis 51
Feb 16, 2018: Allergan Presents Data at the 2018 American Academy of Dermatology (AAD) Annual Meeting in San Diego 52
Feb 06, 2018: Allergan Reports Total Net Revenue Of $4.33 Billion In The Fourth Quarter Of 2017 54
Jan 08, 2018: Allergan Provides 2018 Preliminary Financial Outlook for Select Income Statement Categories and Other Updates at 36th Annual J. P. Morgan Conference 58
Jan 04, 2018: Allergan to cut over 1,000 jobs to reduce costs 59
Dec 18, 2017: Allergan Announces Promotion of Wayne Swanton to Executive Vice President, Global Operations 60
Nov 08, 2017: Allergan to Present Dynamic Eye Care Data at American Academy of Ophthalmology Meeting in New Orleans 61
Nov 01, 2017: Allergan Reports Solid Top-Line Execution in Third Quarter 2017 with 11% Increase in GAAP Net Revenues to $4.03 Billion 62
Oct 11, 2017: Allergan to Present Data From More Than 20 Abstracts at the 2017 Fall Clinical Dermatology Conference 66
Oct 05, 2017: Allergan Presents Data From Seventeen Abstracts At The 2017 American Society For Dermatologic Surgery Meeting In Chicago 67
Section 6 Appendix 69
Methodology 69
Ratio Definitions 69
About GlobalData 73
Contact Us 73
Disclaimer 73

List Of Tables

List of Tables
Allergan Plc, Key Facts 6
Allergan Plc, Key Employees 7
Allergan Plc, Key Employee Biographies 8
Allergan Plc, Major Products and Services 10
Allergan Plc, History 12
Allergan Plc, Other Locations 24
Allergan Plc, Subsidiaries 24
Allergan Plc, Key Competitors 40
Allergan Plc, Ratios based on current share price 41
Allergan Plc, Annual Ratios 42
Allergan Plc, Annual Ratios (Cont...1) 43
Allergan Plc, Annual Ratios (Cont...2) 44
Allergan Plc, Interim Ratios 46
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 48
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 49
Allergan Plc, Recent Deals Summary 50
Currency Codes 69
Capital Market Ratios 69
Equity Ratios 70
Profitability Ratios 70
Cost Ratios 71
Liquidity Ratios 71
Leverage Ratios 72
Efficiency Ratios 72

List Of Figures

List of Figures
Allergan Plc, Performance Chart (2013 - 2017) 45
Allergan Plc, Ratio Charts 47
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 48
Allergan Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 49

Allergan plc - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Allergan plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Allergan plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports

USD 350 View Report

Allergan Plc (AGN) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical

USD 250 View Report

Allergan plc - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Allergan plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Allergan plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports

USD 350 View Report

Allergan Plc (AGN) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available